Categories: The Charlton Centre

News From the International Menopause Society Meeting in Vancouver

Carolyn Whiskin and Kerry Roberts, two of our pharmacists at Charlton, have just returned from the International Menopause Society Meeting in Vancouver. They are both Certified Menopause Practitioners and were very proud to be attending, as this is the first time this meeting has been hosted in Canada. Presenters from around the world shared their research and many new treatments not yet available in Canada were discussed.

One of the first areas discussed was the amount of menopausal hormone replacement prescribed to patients. Although up to 46% of women go to their health professional with menopausal complaints, only 10% or women receive hormone replacement therapy. This is in part due to the lack of awareness surrounding the most recent evidence: that the benefits of hormone replacement outweigh the low level of risk. IMPART is an online series of educational modules for health professionals designed as a refresher course in the treatment of peri-menopausal and menopausal women. It was launched at the conference and is available through the International Menopause Society’s website at no charge. Experts from around the world wrote the content which will updated on a regular basis. We invite you to share this information with your healthcare practitioners.

We will be sharing some of the information learned at this meeting over the next few weeks.


Carolyn Whiskin is the Pharmacy Manager for Charlton Health.  Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Recent Posts

Bimzelx Now Approved for Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…

4 days ago

Happy Holidays from Charlton Health

As the year comes to a close, we wish you a joyful holiday season filled…

3 weeks ago

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 month ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

2 months ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

2 months ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

3 months ago